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Individual bacteria in complex microbial communities can acquire and accumulate new traits. 
These traits are reflective of their environment, being niche-specific. A major player in trait 
sharing is horizontal gene transfer (HGT). Plasmids, extrachromosomal DNA molecules, have 
a role in HGT and can change the host’s phenotype. Considering the transformative role of 
plasmids in bacterial lifestyle, we investigated the prevalence, distribution and products of 
biosynthetic gene clusters (BGCs) present in plasmids. Sequences available on the National 
Center for Biotechnology Information (NCBI) database (n=101 416) were run through two 
bioinformatic pipelines for BGC detection that apply different approaches, deepBGC and 
antiSMASH (antibiotics and secondary metabolites analysis shell). The highest percentage of 
plasmids with BGCs was detected in Actinobacteria but, apart from Chlamidiae and 
Tenericutes, all phyla had BGCs in their plasmids, with predictions varying according to the 
software used. The BGCs identified comprised a range of classes, indicating that plasmid-
encoded BGCs could be leveraged for the discovery of new molecules. In order to apply that 
concept to real-life examples, plasmids were isolated from animal-associated microbial 
communities and characterized. Plasmids from Escherichia coli isolated from wild birds 
(n=36) were screened for phenotypes of interest in human and animal health. Seven isolates 
displayed plasmid-encoded antibiotic resistance. Taxonomic identification of the hosts of 
plasmids isolated from bovid-associated microbiomes (n=38) was determined via 16S rRNA 
gene, and placed the majority of the isolated in the phylum Firmicutes, apart from a single 
Klebsiella pneumoniae isolate. Twelve plasmids were sequenced. Three plasmids from 
different hosts (pRAM-12, pRAM-19-2 and pRAM-30-2) shared 100% nucleotide sequence 
and a gene cluster for the bacteriocin cloacin. Two of those hosts shared not one, but two 
plasmids, pRAM-19-1 and pRAM-30-1, despite being in different phyla. This highlights the 
intimacy of gene sharing and the importance of HGT. pRAM-28 and pRAM-21 shared a 
plasmid that harbors the BGC for the bacteriocin aureocin A70, the only four peptide 
bacteriocin known to date. Additional analysis revealed two putative novel lanthipeptide gene 
clusters in pRAM-2. These results suggest that the plasmidome is a neglected source of 
secondary metabolites with the potential for molecule discovery. Furthermore, it can be 
leveraged to study genetic exchange in a community and how plasmid-encoded featured can 
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Although we have studied individual pathogens since the nineteenth century, only 
recently have we come to appreciate the role microbial collectives play in health and 
disease. These microbiomes, which are defined by members and habitat, play roles in the 
prevention, causation, or aggravation of human and animal disease. A common feature of 
microbiomes is functional redundancy among their members1,2. This redundancy is 
created by two different paths: recruitment of bacteria that share traits or trait sharing 
between bacteria. Specific recruitment implies a long, well-established system that has 
co-evolved. Trait-sharing among bacteria can happen on a much shorter timescale. 
Despite the redundancy encoded within any microbiome, an individual bacterial 
genome is dynamic3–5. A bacterial genome generally consists of a single chromosome and 
can include one or more plasmids. The conserved chromosomal genes (or core genome) 
allow us to relate individuals to each other and a common ancestor. The flexible genome, 
the genes that are not conserved in a species, is known for passing on specialized 
biological functions. These are called accessory genes and can facilitate rapid adaptation. 
Therefore, metabolic functions and habitat-specific interactions can be understood by 
studying the flexible genome3.  
Accessory genes can be acquired through horizontal gene transfer (HGT), a 
process that allows the acquisition of new genetic traits and can contribute greatly to 
bacterial adaptation and functional innovation3,6. These can carry big implications for 
both an individual and a microbial community since bacteria can transition from a 
commensal to a pathogenic lifestyle via HGT4,5,7. Gene transfer can have a significant 
effect on a bacterium phenotype and the structure of the microbial community4,5. A 
primary example of accessory genes that are often exchanged among bacteria is plasmids. 
These extrachromosomal, self-replicating DNA units can be associated with the 
adaptation to environmental pressures and the emergence of new traits that a bacterium 
can leverage to thrive in challenging settings. 
 Current plasmidomic studies are often the result of nucleotide sequence-based 
metagenomics in which the total DNA content of a microbial community is sequenced8,9. 
The annotation of genes and gene clusters harbored in plasmids are frequently the result 
of the study of specific genes or biosynthetic gene clusters (BGCs) on a case-by-case 
basis. Therefore, plasmid-encoded traits are not uncovered by the prioritization of this 
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genetic space, but by a plasmid-by-plasmid basis. Furthermore, metagenomics studies 
analyse plasmids without knowledge about their host bacteria. This thesis uses a 
systematic approach that prioritizes the plasmidome of culturable bacteria as a rich source 
for the discovery of gene clusters with products that can be leveraged for both human and 
animal health. Focusing on the plasmidome and its phenotypes can allow us to shed a 
light on virulence mechanisms related to disease emergence, bacterial interactions, and 
antimicrobial resistance. Improving our understanding of how virulence factors operate, 
how resistance is mounted, and how bacteria compete with each other can, ultimately, be 
used as basis for development of antimicrobial treatment strategies and new therapies.
 13 
2 Literature review 
 
2.1 Plasmid-encoded phenotypes of interest for human and animal medicine 
 
Plasmids are self-replicating extrachromosomal DNA molecules that can be shared by 
bacteria through several mechanisms10. Conjugation, transformation, and transduction are the 
three canonical mediators of DNA transfer in bacteria4,5. Conjugation occurs when a donor 
bacterium makes direct cell contact with a recipient bacterium, using a conjugative pilus. 
Transformation is the natural process of DNA uptake from the environment, such as from 
surrounding bacteria that have been lysed, while transduction occurs when a bacteriophage 
acquires a fragment of bacterial genetic information and infects another bacterium. Recently, 
other mechanisms of DNA transfer were identified, such as nanotubes11, which are structurally 
different from conjugative pili, and extracellular vesicles (exosomes)12.  
Gene transfer can have a significant effect on a bacterium phenotype and the structure 
of the microbial community4,5. A primary example of accessory genes that are often exchanged 
among bacteria is plasmids. These extrachromosomal, self-replicating DNA can be associated 
with the adaptation to environmental pressures and the emergence of new traits that a bacterium 
can leverage to thrive in challenging settings. 
The acquisition or loss of a plasmid can drastically alter a bacterial phenotype. It has 
been correlated to the development of virulent phenotypes attributed to small molecules13–16. 
This extrachromosomal DNA can also encode for protein toxins, antibiotic resistance, secretion 
systems, and iron-scavenging molecules named siderophores17,18. Plasmid-encoded 
pathogenicity has been shown for Vibrio crassostreae, a benign colonizer of oysters that 
becomes pathogenic when carrying the plasmid pGV1512. Interestingly, though the pathogenic 
phenotype has emerged, none of the genes encode for known virulence factors15. The fish 
pathogen Vibrio anguillarum has two phenotypes related to plasmid acquisition: the production 
of a siderophore named anguibactin, and a virulence system that encodes for a potent 
enterotoxin, both encoded by the plasmid pJM113,14. The bacteria Staphylococcus aureus can 
produce an exotoxin that causes blisters in humans and animals when carrying an ETB plasmid. 
Moreover, the emergence of ETB plasmids containing multiple antibiotic resistance genes, 
which is a potential problem for human and animal health, has also been reported19. Despite 
the bias toward the study of pathogens, plasmids can also help non-pathogenic bacteria 
overcome limited resources and niche occupancy, as is the case of plasmid-encoded small 
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molecules such as 9-methoxyrebeccamycin, an analog of the antitumoral agent rebeccamycin 
encoded on plasmid pBCI2-220–24. 
 
2.2 Classes of natural products  
 
2.2.1 Ribosomally synthesized and post-translationally modified peptides 
 
One of the classes of small molecules that has attracted attention from both the academy 
and industry due to the rapid discovery of new molecules, structural diversity and functional 
variability is the Ribosomally synthesized and post-translationally modified peptides 
(RiPPs)25–28. Bioactivity from these small molecules ranges from targeting DNA gyrase29 and 
RNA polymerase30 to cell membranes31,32. Despite great diversity of structures, their 
biosynthesis and minimal gene cluster composition has common features, which allow 
researchers to classify them as RiPPs. 
A precursor peptide that includes an N-terminal leader and a C-terminal core peptide 
and modifying enzymes constitute the minimal components of a RiPP BGC28. Different post-
translational modification enzymes will install different moieties, which will result in the 
various classes of RiPPs26,28. The biosynthesis starts with the synthesis of a precursor peptide. 
Most RiPP precursors have a leader peptide attached to the N-terminal of the core peptide. An 
exception are the bottromycins, where the leader region is at the C-terminus and was termed 
follower peptide33–35. The leader sequence is recognized by the post-translational modification 
enzymes, as well as by the export system, while the core region is modified to become the 
mature, active RiPP25–28 (Figure 2.1). 
 Recently, new sequencing techniques coupled with genome mining approaches allowed 
researchers to link known product classes with biosynthetic gene clusters, and the exploration 
of novel BGCs resulted in new RiPP classes. These new classes, as well as defining 
characteristics of all RiPPs families, covering research up to June 2020 were reviewed in detail 
by Montalbán-López et al. (2020)36. Seventeen new classes were recently described, and Table 
2.1 presents a summary of all currently known classes of RiPPs, their defining features, as well 




Figure 2.1: Schematic overview of the biosynthesis of RiPPs. The precursor peptide is 
composed of a leader and a core region. The core peptide will be transformed in the mature 
peptide. The post-translational modifications enzymes vary depending on the family of RiPPs, 
and are guided by the recognition of the leader peptide and recognition sequences. After 
tailoring reaction(s), the leader peptide is cleaved from the core, and the mature peptide is 
exported from the cell. 
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Table 2.1: Known RiPP classes, their defining features, class representative and, if applicable, 
plasmid-encoded example (Adapted from Montalbán-López et al. (2020)). 
Class Example Defining feature Plasmid-encoded 




A2 and B39, pep540 
Linaridins Cypemycin 
Dehydrobutyrine (Dhb), no 
lanthionines 
 
Proteusins Polytheonamides Nitrile hydratase leader peptide  
Linear azol(in)e-containing 
peptides (LAPs) 
Streptolysin S Azol(in)es 
Microcin B1729,41–
43 
Cyanobactins Pattelamide N-terminal protease  
Thiopeptides Thiostrepton 
[4 + 2] cycloaddition of two 
dehydroalanines (Dha) 
lactocillin44, MP145 
Bottromycins Bottromycin A2 Macrolactamidine  
Microcins Microcin C 
Low molecular mass peptides, 
produced by Enterobacteriaceae 
Microcins C (both 
C746 and C5147), 
microcin D9348, 
microcin PDI49 
Lassopeptides Microcin J25 
Macrolactam with threaded C-
terminal tail 
Microcin J2530,50–
52; citrocin* 53 




Sactipeptides Subtilosin A Sactionine crosslink Bacthuricin F454,55 
Bacterial head-to-tail cyclized 
peptides 
Enterocin AS-48 N-to-C cyclization Acidocin B56 
Glycocins Sublancin 168 S, O-glycosylation of Ser/Cys ASM157 
Autoinducing peptides AIP-1 Cyclic ester/thioester  
ComX ComX168 Indole cyclization and prenylation  
Methanobactins Methanobactin Oxazolones  
Thioamitidies Thioviridamide Backbone thioamide  
Dikaritins Ustiloxin Tyr-Xxx ether crosslink  
Guanidinotides Pheganomycin a-Guanidino acid   
Mycofactocin Mycofactocin Val–Tyr crosslink  
Streptides Streptide Trp–Lys crosslink  
Borosins Omphalotin 
Amide backbone N-methylation, N-
to-C cyclization 
 
Crocagins Crocagin Indole-backbone cyclization  
Epipeptides YydF D-Amino acids  











Cyclotides Kalata B1 N-to-C cyclization, disulfide(s)  
Pearlins Thiaglutamate aa-tRNA derived  
Atropitides Tryptorubin 
Aromatic amino acids crosslinked 
resulting in a non-canonical 
atropisomer 
 
Cittilins Cittilin A 
Biaryl and aryl–oxygen–aryl ether 
crosslinks 
 
Orbitides Cyclolinopeptide A N-to-C cyclization; no disulfides  
Pantocins Pantocin A Glu–Glu crosslink  
Rotapeptides TQQ Oxygen-to-a-carbon crosslink  
Sulfatyrotides RaxX Tyrosine sulfation  
Pyrroloquinoline quinones PQQ Glu–Tyr crosslink  
Amatoxins/phallotoxins Phalloidin 








Polyketides (PKs) comprise a class of natural products found in bacteria, fungi, plants 
and animals, that presents distinct structures and widely diverse clinical applications58–60. This 
class includes the antibiotics erythromycin61 and tetracycline62, the antifungal amphotericin63, 
as well as the antiparasitic ivermectin64. The mycolactone produced by Mycobacterium 
ulcerans is a cytotoxic macrolide that is plasmid encoded18, and so is mycolactone F, a unique 
toxin produced by the fish pathogen Mycobacterium marinum65. Two macrolide antibiotics, 
lankacidin and lankamycin, are encoded on a plasmid66. Curiously, the same plasmid carries 
two additional BGCs, for the production of a cryptic type II polyketide and carotenoids, making 
two-thirds of the plasmid responsible for secondary metabolism genes. 
The complex biosynthesis of polyketides involves the multifunctional enzymes 
polyketide synthases (PKSs)60,67. A simplified version of mycolactone synthesis is shown in 
Figure 2.2. These multi-domain enzymes harbor acyltransferase (AT), ketosynthase (KS), and 
thioestherase (TE), as well as optional domains, such as ketoreductase (KR), enoylreductase 
(ER) and dehydratase (DH). Based on the structural architecture and enzymatic mechanism, 
PKSs have been divided into three types60,68,69. Type I PKSs are multienzyme complexes with 
modules fused covalently. Each individual module has several domains (AT, KS, TE, KR, etc.), 
in order for the catalyzing reactions to assemble the final polyketide. Type II PKSs are 
monofunctional enzymes, each responsible for a specific reaction in the polyketide assembly 
line. This type of PKS is mainly found in bacteria and generates aromatic compounds. Type III 
PKSs are usually found in plants, although three PKSs identified in mycobacterium genome 
also belong to type III60. These PKSs are simple homodimers, and function independently of 
the acyl carrier protein (ACP) domain. 
The biosynthesis of polyketides has been divided into cis-AT PKS and trans-AT PKS70. 
In the cis-AT biosynthesis, the starter unit acyl-Coenzyme A (CoA) is loaded on the ACP, 
catalyzed by the AT domain59. The elongation of the carbon chain occurs catalyzed by the KS 
domain. Different structures can be added by other additional domains, such as KR, DH and 
ER. The TE domain then terminates the elongation process by hydrolysis or cyclization of the 
polyketide chain from the ACP domain. The trans-AT biosynthesis involves PKSs that lack 
the AT domains70. The activity of these domains in each elongation step is provided by proteins 
encoded in the BGC. 
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Figure 2.2: Simplified biosynthesis of the polyketide mycolactone, product of a BGC harbored by the pMUM001 plasmid. MLSA1 and MLSA2 
are modular PKSs encoded by the genes mlsA1 and mlsA2. The starter unit acyl-CoA is loaded on the ACP, catalyzed by the AT domain (loading 
module not depicted). The carbon chain is elongated by the KS domain. Further elongation and modifications occur in each module, until the 
elongation is terminated by the TE domain via hydrolyzation and/or cyclization of the completed molecule from the ACP domain. 
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2.2.3 Non-ribosomal peptides 
 
With diverse structure range, and a vast sphere of activity, non-ribosomal peptides 
(NRPs) can be differentiated from ribosomally synthesized peptides through structural features 
and their biosynthesis71,72. NRPs have structures that are usually macrocyclic or branched 
macrocyclic, with dimers and trimers of identical elements. Non-proteinogenic amino acids 
can be included, such as ornithine or (di)hydroxyphenyl-glycine. These peptides can also have 
fatty acids incorporated, and acetate and propionate units can be inserted. N-methylations, N-
formylations and glycosylations can also be present. Anguibactin, a siderophore produced by 
Vibrio anguillarum, is one of the known plasmid-encoded NRPs73. Recently, a pediocin-like 
peptide was identified, with broad spectrum activity against the pathogen Listeria 
monocytogenes74. This peptide also has its BGC harbored in a plasmid. 
The biosynthesis of NRPs is dependent on the megaenzymes non-ribosomal peptide 
synthetases (NRPSs)71. These enzymes are able to process hundreds of monomers and have a 
modular organization, where each module (section) of the NRPS is responsible for the addition 
of one amino acid to the final peptide75. The minimal components for the peptide elongation 
step are an adenylation (A) domain, a peptidyl carrier protein (PCP) domain, and a 
condensation (C) domain71,75,76. The chain initiation involves an A domain selecting the 
substrate and activating it as an aminoacyl-adenylate. The PCP domain is a transport unit, 
which allows the movement of the activated amino acids and elongation intermediates between 
catalytic centers. It carries the acyl-intermediates on the –SH group of its cofactor 4’-
phosphopantetheine (acyl-S-PCP intermediate). The two modules are condensed by the C 
domain, which catalyses a peptide bond between the adjacent modules. The termination of the 
peptide chain is done by the release of the peptide, by a thioesterase (TE) domain, by hydrolysis 
or cyclization (Figure 2.3). 
Hybrid BGCs of polyketides and non-ribosomal peptides can be found in nature, with 
different biological activities such as the antibiotic leinamycin77, the antitumor drug 
bleomycin78, and the siderophore yersiniabactin79. The combination of PKs and NRPs is 
typically synthesized by PKS and NRPS modules in certain order in the assembly line80. A 
second, different mode of biosynthesis can be found in fungi and was reviewed by Fisch (2013). 






Figure 2.3: Schematics of a linear non ribosomal peptide biosynthesis. Each module is 
responsible for the addition of a single residue. Using an assembly-line-like structure, the 
substrate is adenylated (activated). The thiol group of the pantetheine cofactor of the peptide 
carrier protein is used as a shuttle between the modules (catalytic domains). The amide bond 
formed between the substrates is catalyzed by the condensation domain. A thioesterase 
recognizes the mature peptide and cleaves it from the NRPS machinery, often macrocyclizing 





Terpenes are a structurally diverse class of secondary metabolites and, despite being 
the largest class of secondary metabolites (over 80,000 known terpenes82), only a small fraction 
of the terpenoid metabolites have been connected to bacteria82–84. Recent bioinformatic 
screening studies have shown that terpene synthases are widely distributed in prokaryotes84,85. 
A highlight of this is the linear megaplasmid pSCL4, isolated from Streptomyces clavuligerus 
ATCC 27064, which harbors twelve putative BGCs with one or more terpene synthases or 
cyclases86. 
 The terpene biosynthesis starts with the creation of a linear polyene with branching 
methyl groups. This is done by joining multiple five-carbon units (isoprenes). This linear 
methyl-branched polyene is held in a defined conformation by a terpene cyclase, initiating a 
series of rearrangements and cyclizations. This hydrocarbon skeleton can be modified to a wide 
variety of conformations, and sugars, fatty acids and amino acids can be added to the 
structure83.  
 
2.3 Bioinformatic approaches for the discovery of BGCs 
 
Computational tools have been used to identify BGCs in nucleotide sequences since the 
beginning of bacterial genome sequencing87–89. It started with simple comparison techniques 
and, currently, a spectrum of software tools is available. Years of bacterial genome analysis 
revealed that specialized metabolites are often synthesized by metabolic pathways encoded by 
genes assembled next to each other. Therefore, leveraging gene clustering in prokaryotes, 
coupled with the understanding of the biosynthetic logic of different classes of natural products 
is used in several bioinformatic methods to detect secondary metabolites. 
Currently, a range of tools are available to detect bacterial BGCs (Table 2.2). Fungal 
secondary metabolites can be detected by antiSMASH90, SMURF91 and TOUCAN92. 
Bioinformatic tools have been successfully applied to genome mining, resulting in the 
discovery of various molecules with a range of bioactivities, belonging to different families of 
natural products. Such is the case of the lasso peptides burhizin-2393, mycetohabin-1693, 
mycetohabin-1593, and specialicin94, the terpenoid antibiotic family tiancilactone95, the non 
ribosomal peptides brevicidine96, laterocidine96, and paenibacterin B96, the alkaloids 
argimycins P97, and a newly reported class V of lanthipeptides98.  
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Table 2.2: Currently available bioinformatic tools for detection of bacterial secondary 
metabolite gene clusters. 
Bioinformatic tool  Key features  Reference 
antiSMASH  
Identifies different types of BGCs, with in depth 




Applies a deep learning strategy coupled with 
random forest classifiers to predict compound 
classes and potential chemical activity 
 100 
PRISM  
Detects 22 secondary metabolites types; allows 
for structure prediction 
 101 
ClusterFinder  
Uses a probabilistic algorithm to identify BGCs 
of known and unknown classes 
 102 
EvoMining  
Incorporates evolutionary principles with 
phylogenomics to genome mining 
 103 
C-Hunter  




Screens for natural product BGCs; outputs 
NRPs’ and PKs’ chemical structures 
 105 
ClustScan  
Detects modular enzymes such as PKS, NRPS 
and hybrid PKS/NRPS enzymes 
 106 
CLUSEAN  
Integrates BLAST and HMMer to identify motifs 
and domains in NRPSs and PKSs 
 107 
NRPSpredictor  
Applies machine learning to predict substrate 
specificity of NRPSs 
 108 
BAGEL  
Uses core peptide database and HMMs to 
identify RiPPs and bacteriocins 
 109 
DeepRiPP  Incorporates genomic and metabolomic data   110 
SeMPI  
Specialized screening of available databases to 
predict PK and NRP scaffolds 
 111 
NeuRiPP  
Trained neural network on precursor peptides 
(PP) datasets, allowing for identification of 
known PP as well as likely PP sequences 
 112 
RiPPMiner  
Uses a machine learner classifier coupled with a 
curated database of >500 characterized RiPPs  
 113 
RODEO  
Combines HMMs and machine learning to 
predict precursor peptides, although initially 
focused solely on lasso peptides 
 114 
PKMiner  
Classifies domains to predict BGCs with type II 
PKSs and aromatic polyketides based on 
aromatase and cyclase domains 
 115 
RiPPer  
Identifies precursor peptides independent of the 
family of RiPPs 
 116 
RRE-Finder  
Detects RiPPs based on the RiPP recognition 
element, which binds to the precursor peptide 
 117 
decRiPPter  
Integrative algorithm that allows the discovery of 




This thesis focuses on two programs used to detect and identify a range of secondary 
metabolite gene clusters: antiSMASH and deepBGC. antiSMASH (antibiotic and secondary 
metabolite analysis shell) was developed in 2011119 and is currently in its sixth version99. It 
comprises a software pipeline that can be used either in the web-server form 
(http://antismash.secondarymetabolites.org/) or as a stand-alone on a personal computer. The 
software uses the machine learning algorithm Prodigal or the interpolated Markov modeller 
Glimmer to detect open reading frames (ORFs) in the raw input sequences. The detection of 
the biosynthetic gene clusters is done by applying profile Hidden Markov Models (pHMMs) 
through the HMMer tool. All protein-encoding genes are analyzed with pHMMs based on 
alignments of signature proteins and protein domains to a library that provides models of 
signature genes and scaffolds for a range of secondary metabolites. False positive pHMMs are 
used to avoid misclassification of homologous structures, such as fatty acid synthases. Rules 
that define what needs to exist in order to constitute a biosynthetic gene cluster are manually 
curated and validated. The current version contains rules for 71 different BGCs. Another set of 
pHMMs is used to detect NRPS/PKS domains and predicts substrate specificity, 
stereochemistry and structure of the molecule. A comparison tool using the annotated database 
is then applied to attempt a functional understanding of the BGC. In order to predict unknown 
BGCs that could be missed by the antiSMASH detection module, a framework for automated 
detection of BGCs is used. Predicted Pfam domains are fed to an HMM. This allows for 
detection of BGCs in a more generalized way. The results of this pipeline are visualized in an 
interactive XHTML page. Gene clusters that were identified are shown in different colors, 
based on the classification. Furthermore, antiSMASH has a database of BGCs 
(https://antismash-db.secondarymetabolites.org/) detected in nucleotide sequences available 
from the National Center for Biotechnology Information (NCBI) GenBank120. An evolutionary 
context can be drawn from the comparison of the queried BGC with all known gene clusters, 
resulting in a better understanding of the secondary metabolite and assumption of gene 
functions based on the sequence homology. It also permits the user to browse by phylogeny or 
metabolite type, and provides statistics about the natural products in the database.  
deepBGC has been available since 2019100. It also uses Prodigal to predict ORFs. 
However, it exploits the Pfam database using HMMer to predict protein domains. Because 
protein families represent functional elements in the gene clusters, they are useful for BGC 
identification. The Pfam domains are converted into numeric vector representations that take 
superfamily similarities into account. This is fed to a bidirectional long short-term memory 
(BiLSTM) neural network, composed of three layers. The input layer, which is comprised of 
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Pfam domains in their genomic order, in the form of sequential numerical vectors. The 
BiLSTM layer, composed of a network of forward and backward LSTM layers. These are basic 
memory cells with 128-dimension hidden state vector. This acts as the neural network memory, 
holding the information on the data the network processed before. The output from all the 
LSTM cells is refined by a single output layer with a sigmoid function: this provides a single 
value for each Pfam. This score for the Pfam domain represents the BGC classification score. 
The algorithm allows the user to set the minimum score Pfams need to achieve to be considered 
for a putative BGC, the default being 0.5. Consecutive genes are assembled into putative BGCs, 
and compound classes and biological activity are predicted using random forest classifiers. 
Despite the variety of bioinformatic tools available to detect BGCs, the use of software 
to predict secondary metabolites gene clusters has its limitations121. With the constant update 
on the current knowledge of biosynthetic pathways, new families can be missed or 
misclassified. Prediction of compound structures based on genetic knowledge is often used to 
dereplicate natural products and focus on new molecules. However, tailoring enzymes cannot 
be predicted as precisely as core biosynthetic enzymes, which in turn results in inaccurate 
structure prediction. Additionally, bioactivity cannot always be inferred, challenging activity-
based prioritization. Translating bioinformatic results to novel natural products is also a 
potential challenge, since silent and/or low-expressing BGCs require synthetic biology tools to 





Taking in consideration that plasmids are key players in HGT, can contribute to phenotypes 
of interest for human and animal health and, historically, the plasmidome is not a prioritized 
genetic space, this work aimed to: 
1. Determine the prevalence, taxonomic distribution, and type of product encoded by 
BGCs present in publicly available plasmid sequences using two different 
bioinformatic approaches. 
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The role played by microbial communities in prevention, causation and aggravation of health 
states has only recently become appreciated. The members of any microbiome have functional 
redundancy. This redundancy occurs in two ways: recruitment of bacteria that share traits or 
trait sharing between bacteria. While the first is a co-evolved system, the second can happen 
on a shorter timescale and results in rapid evolution through the acquisition and accumulation 
of new traits. These traits can reflect a bacterium’s environment, since they are niche-specific. 
Horizontal gene transfer (HGT) plays a major role in trait redundancy, since traits are encoded 
by genes. Plasmids, self-replicating extrachromosomal DNA molecules, are major participants 
in HGT. The acquisition or loss of a plasmid can drastically alter an individual’s phenotype. 
Plasmid-encoded phenotypes include antibiotic resistance, virulence factors and bioactive 
small molecules. To better understand the prevalence, taxonomic distribution and products of 
BGCs harbored in plasmids, the sequences of complete plasmids available on the National 
Center for Biotechnology Information (NCBI) database were analysed with the software 
deepBGC and antiSMASH (antibiotics and secondary metabolites analysis shell) to predict the 
presence of secondary metabolites biosynthetic gene clusters (BGCs). Actinobacteria was the 
phylum with the highest percentage of plasmids with BGCs, followed by Cyanobacteria and 
Proteobacteria. At least one BGC was identified in 8.48 to 25.5% of the plasmids, varying 
according to software used. Averages of 1.1 and 2.64 BGC/plasmid were observed with 
antiSMASH and deepBGC, respectively. BGCs were detected across all phyla, suggesting 





Bacterial metabolites (secondary or specialized) comprise a preeminent source of 
bioactive compounds. These molecules can be classified based on an array of chemical 
structures or biological activities87–89. Secondary metabolites are biosynthesized by metabolic 
pathways encoded by adjacent genes. These biosynthetic gene clusters (BGCs) encode the 
necessary enzymes, regulatory proteins, immunity proteins and transporters for the 
biosynthesis and export of the specialized metabolite. With the development of computational 
toolkits, these characteristics allow for computational identification of BGCs in DNA 
sequences.   
Among the current available approaches to detect BGCs, deepBGC100 is the newest 
software available to identify BGCs of different product classes. It uses the Prodigal algorithm 
to predict genes in the raw input sequence. Each of the genes detected are assigned to a protein 
family (Pfam) domain using HMMer. The software transforms each of the Pfam domains in a 
numeric vector, which is input to a bidirectional long short-term memory recurrent neural 
network (BiLSTM RNN). The BiLSTM layer of the software analyzes each Pfam domain in 
genomic order. The vector has binary flags that indicate where the domain is found in the 
protein (beginning or end). The memory cell processes the input layer and all previously seen 
Pfam, while the backward layer does the vector analysis in reverse order. The output from both 
memory cells is converted and results in a BGC score for the Pfam domain. Based on the 
classification scores, consecutive candidate genes are assembled to putative BGCs. Random 
forest classifiers are used to predict compound class and biological activity, which are then 
output to the user. 
antiSMASH (antibiotic and secondary metabolite analysis shell) has been a popular free 
computational toolkit since it was established in 201199, with over 750 000 jobs processed in 
the web server120. Similar to deepBGC, antiSMASH uses Prodigal to detect open reading 
frames (ORFs) in the raw input sequence. A set of profile hidden Markov models (pHMMs) 
related to BGCs is applied in the input data. A set of manually curated and validated rules for 
different BGCs is used in the pHMMs. These specialized libraries allow the software to detect 
and catalog the various subclasses of the secondary metabolites. An algorithm to identify 
regions rich in Pfam domains runs in parallel. Finally, a filter for the cut-offs using the known 
minimal core components of each BGC class is applied. antiSMASH has a database of BGCs 
detected in nucleotide sequences available on GenBank. The database is used to compare the 
identified gene cluster to all known gene clusters, resulting in an evolutionary context that 
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provides more understanding of the role of the specialized metabolite. This allows assumption 
of gene functions based on sequence similarity, which is then output to the user. 
To better understand the prevalence, taxonomic distribution and products of BGCs 
harbored in plasmids, the sequences of complete plasmids available in the National Center for 
Biotechnology Information (NCBI) nucleotide database were analysed with deepBGC and 
antiSMASH to predict the presence of secondary metabolite BGCs. 
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3.3 Materials & Methods 
 
3.3.1 Input sequences 
 
Complete sequences of plasmids available in the National Center for Biotechnology 
Information (NCBI) nucleotide database were downloaded in FASTA format, which is 
accepted by both software. The query was performed in November 2020, using “plasmid” and 
“complete sequence” as key words. The database allows for dividing the results by either 
organism classification (e.g., Escherichia coli, Staphylococcus aureus) or by phylum. The 
second option was chosen and the sequences were downloaded divided by phylum of plasmid 
host.  
 
3.3.2 BGC identification and classification 
 
The analysis was performed in the High-Performance Computing (HPC) Centre at the 
University of Saskatchewan. The software used were deepBGC version 0.1.26, and 
antiSMASH version 6.0 beta, with the default settings. This version of the deepBGC software 
provides a .json file output, that can be uploaded in the antiSMASH website, along with the 
sequence file. The version of antiSMASH that allows the upload of files from other software 
was only available by the website access, not in the standalone mode, at the time of this study. 
By uploading the .json file from the deepBGC output in the antiSMASH website, the 
results of both programs can be seen side by side. However, the maximum size of input to the 
website is 150 MB. The sequence files that were over this limit were split and uploaded 
individually. Outputs were assessed individually and summarized by phyla. 
 
3.3.3 Data analysis 
 
In order to facilitate comparison of BGCs identification and classifications, the output 
of the both software had to be standardized. The nomenclature utilized for comparison of 
results was the one used by deepBGC, and it is shown in Table 3.1. deepBGC has an additional 
category, “no confident class”, with no equivalent in the antiSMASH output. The data from 
this class were analyzed separately. 
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Table 3.1: Biosynthetic gene cluster product classification by the software used in this study. 
In the first column, the nomenclature used by deepBGC and applied to the classification results 
from both software. In the second column, the nomenclature used by antiSMASH 
deepBGC antiSMASH 
Polyketides 
Type I PKS 
Type II PKS 
















































A total of 101 416 plasmid sequences were retrieved from the Genbank search: 
Fusobacteria (89); Chlamydiae (295); Tenericutes (296); Cytophaga, Fusobacterium, and 
Bacteroides (CFB) (566); Cyanobacteria (1377); Spirochaetes (5529); Actinobacteria (2186); 




The software deepBGC detected an average of 2.64 biosynthetic gene clusters per 
plasmid, with a total of 86139 BGCs identified. According to this software, 25.5% of the total 
set of plasmids harbor BGCs (Table 3.2). The distribution of BGC product classes detected by 
deepBGC in the total plasmid data set analyzed is shown in Figure 3.1. 
The compound classes are predicted by random forest classifiers. One feature of this 
software is the “No confident class” category, for BGCs that cannot be positively assigned and, 
therefore, represent a plausible source for the discovery of novel gene cluster products and 
classes. The range of BGCs that could not be confidently classified by the software was 
between 64 (Firmicutes) and 94% (Spirochetes) of the detected gene clusters across all phyla 
analyzed (Figure 3.2). 
Although virulence factors and antibiotic resistant phenotypes have been linked to the 
presence of plasmids in Chlamydiae, no BGCs were identified by deepBGC in plasmids from 
the Chlamydiae phylum. The other phyla had at least four biosynthetic gene clusters identified 
in their set of plasmids (Figure 3.3). The only detected product class that was common across 
all phyla was ribosomally synthesized and post-translationally modified peptides (RiPPs). With 
the exception of Cyanobacteria and Actinobacteria, all the other phyla had the largest portion 
of their gene cluster products identified as RiPPs, with all the detected gene clusters on 
Tenericutes plasmids being classified as such. In Cyanobacteria and Actinobacteria plasmids, 
the predominant product class was polyketides.  
The proportion of non-ribosomal peptides (NRPs) products among the plasmids of 
different phyla ranged from 4.3 (CFB) to 27.9% (Cyanobacteria). NRPs gene clusters were not 
identified in Fusobacteria, Tenericutes or Spirochaetes plasmids. Terpene gene clusters 
comprised 50% of the BGCs detected in Fusobacteria and were not detected in plasmids from 
Tenericutes, CFB or Spirochetaes hosts. In the remaining phyla, terpene gene clusters 
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accounted for 4.3% (Firmicutes) to 8.9% (Cyanobacteria) of classified BGCs. Actinobacteria 








Figure 3.2: Proportion of plasmid biosynthetic gene clusters detected by the software deepBGC 
that could not be confidently categorized. Number in parentheses beside the phylum name is 
the number of plasmid sequences analysed. Number on the right-hand end of the graphic is the 




Figure 3.3: Biosynthetic gene cluster product classification by deepBGC and their distribution 
across phyla. Number in parentheses beside the phylum name is the number of plasmids 
analysed. Number on the right-hand of the graphic is the total number of BGCs that were 





A total of 12592 BGCs were identified by antiSMASH, across 8.48% of the plasmid 
sequences. An average of 1.1 BGC/plasmid was detected (Table 3.2). antiSMASH uses a set 
of manually curated pHMMs for different BGCs in its pipeline. The application of specialized 
libraries and a constantly updated database of BGCs permit the identification of various 
subclasses of the secondary metabolites, giving a better resolution of the results. However, to 
facilitate comparison with deepBGC results, these additional subclasses were combined 
according to Table 3.1. Classes of the products detected in BGCs by antiSMASH and their 
distribution is shown in Figure 3.4.  
Similar to the results of the deepBGC, no BGCs were identified in the Chlamydiae 
phylum. antiSMASH also did not detect any BGCs on plasmids from Tenericutes. The other 
phyla had at least two gene clusters identified on their set of plasmids (Figure 3.5). Two phyla 
had 100% of the gene clusters identified on its plasmids belonging to the same class, 
Fusobacteria (NRPs) and Spirochetes (RiPPs). The proportion of BGCs classified as RiPPs 
across phyla varied from 0 (Fusobacteria) to 74.1% (Firmicutes), being the largest parcel of 
BGCs detected in CFB (38%) and Firmicutes. In the other phyla, its representation ranged from 
20 (Actinobacteria) to 30.6% (Proteobacteria). Apart from Fusobacteria, Cyanobacteria 
plasmids had the highest proportion of the detected gene clusters products classified as NRPs 
(42%). This classification otherwise varied from 9.5 (CFB) to 21.4% (Actinobacteria). Terpene 
gene clusters were the least common across all phyla, ranging from 1.2% (Firmicutes) to 13.9% 
(Actinobacteria).  
The classification “Others” was the second most common, being responsible for the 
largest part of the BGCs identified in Actinobacteria and Proteobacteria. A detailed distribution 
of each of the classes assigned as “Others” and the frequency of which each was observed can 
be seen in Figure 3.6. Homoserine lactones and siderophores were the most observed products, 
accounting for 41 and 34.9% of all “Others” classification, respectively. 
Siderophores were the only subclass common to all the five phyla that had BGCs 
classified as “Others” (Figure 3.7). Proteobacteria plasmids presented exclusive classifications 
of BGCs, and are responsible for 100% of the tropodithietic acid, N-acetylglutaminylglutamine 
amide (NAGGN), phenazine, phosphonate, homoserine lactone, and acyl amino acids gene 
clusters. Actinobacteria was the only phylum in which melanin products were observed.  
Known antibiotic molecules (β lactams and aminoglycosides) BGCs were detected on plasmids 
belonging to Actinobacteria and Proteobacteria.  
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Figure 3.4: Distribution of gene cluster product classes detected on plasmids from different 




Figure 3.5: Distribution of the biosynthetic gene clusters products classes across phyla, 
identified by antiSMASH. Number on the right-hand of the graphic is the total number of BGCs 








Figure 3.7: Distribution of BGCs products classifications grouped as "Other" across phyla. Number in the right-hand of the graphic is the total 
number of BGCs of each subclass. 
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3.4.3 Comparison of BGCs detected by deepBGC and antiSMASH 
 
An overall summary of the BGCs detected, as well as BGC/plasmid and the percentage 
of plasmids that harbored BGCs are shown in Table 3.2. deepBGC detected over six times the 
number of BGCs detected by antiSMASH, in addition to twice the average number of 
BGC/plasmid. It is worth highlighting that, in the cases of Proteobacteria, Spirochaetes, 
Actinobacteria, CFB and Fusobacteria, the number of BGCs identified by deepBGC was an 
order of magnitude higher than the detected by antiSMASH. A total of 4732 (4.7%) plasmid 
sequences had BGCs detected by both programs. However, in most cases, the BGCs detected 
did not overlap, despite being in the same plasmid sequence. 
 A comparison of the numbers of classes of natural products detected by each software 
can be seen in Figure 3.8. RiPPs, PKs and Terpenes were identified by deepBGC 2, 5.65 and 
2.45 times more, respectively. antiSMASH detected 150 more BGCs belonging to NRPs than 
deepBGC. While antiSMASH identified more BGCs belonging to “Others”, it is worth noting 
that the parameters for this classification in the deepBGC software are not clear. 
 The distribution of the BGCs classes identified by each software, divided by phylum, 
is shown in Figure 3.9 and Table 3.3. While predictions by the two programs did not agree 
fully in any phylum, some disagreements were more perceptible. The difference in numbers 
can be observed mostly in the classes of RiPPs and PKs in all phyla. Fusobacteria (Figure 3.9G) 
showed no agreement in classifications, despite having two plasmid sequences where gene 
clusters were detected by both programs. All the gene clusters detected by antiSMASH were 
classified as NRPs, while deepBGC classified 50% as RiPPs and 50% as Terpenes.
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Table 3.2: Number of BGCs identified, BGC/plasmid and percentage of plasmids that had BGCs according to each software used. The last column 
shows the number of plasmid sequences that had BGCs detected by both software. 
 
deepBGC antiSMASH 
Sequences that overlap 
BGC identified BGC/plasmid % plasmids with BGCs BGC identified BGC/plasmid % plasmids with BGCs 
Proteobacteria (n=72908) 76047 6.5 29.9 9862 2.1 9.0 3922 
Firmicutes (n=18170) 5391 2.3 13 1673 1.2 7.6 434 
Spirochaetes (n=5529) 227 1.2 3.4 12 1 0.2 6 
Actinobacteria (n=2186) 3185 3.3 44 779 1.9 18.9 258 
Cyanobacteria (n=1377) 989 2.2 33 239 1.3 13.4 102 
CFB (n=566) 260 2.4 19.4 25 1.4 3.2 8 
Tenericutes (n=296) 22 1.4 5.4 0 0 0 0 
Chlamydiae (n=295) 0 0 0 0 0 0 0 
Fusobacteria (n=89) 18 4.5 4.5 2 1 2.25 2 
TOTAL 86139 2.64 25.5 12592 1.1 8.48 4732 
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Figure 3.8: Comparison of the total number of BGCs of each natural product class in the 
plasmid sequences detected by each software tested. 
 45 
 
Figure 3.9: Comparison of the percentage of each class of BGC identified by the software, by individual phylum.  
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Table 3.3: Percentage of gene clusters classified in the different natural product families, according to each software. 
 Proteobacteria Firmicutes Spirochaetes Actinobacteria Cyanobacteria CFB Fusobacteria 
deepBGC antiSMASH deepBGC antiSMASH deepBGC antiSMASH deepBGC antiSMASH deepBGC antiSMASH deepBGC antiSMASH deepBGC antiSMASH 
RiPPs 44.7 30.7 52.1 74.2 57.1 100 15.2 20 24.1 27.2 57.4 38.1 50 0 
PKs 27.6 7.1 20.7 5.7 42.8 0 52.6 17.1 33 22.2 34 14.3 0 0 
NRPs 10.5 19.1 12.9 16.1 0 0 15.6 21.4 27.9 42 4.2 9.5 0 100 
Terpenes 4.8 2.4 4.4 1.2 0 0 8.9 13.9 8.9 2.7 0 9.5 50 0 
Others 12.3 40.8 9.8 2.9 0 0 7.5 27.4 6 5.9 4.2 28.6 0 0 








Sequences of complete plasmids available in the NCBI nucleotide database were 
analysed with deepBGC and antiSMASH to detect the presence of secondary metabolite 
BGCs. This information can be used to better understand the prevalence, taxonomic 
distribution and products of BGCs harbored in plasmids. Ultimately, these results can be 
used to streamline and optimize the discovery of new molecules. As much as bacteria are 
known for being a rich source of bioactive metabolites, apart from Actinobacteria and 
Cyanobacteria, their potential has been mostly underexplored122. In this aspect, this work 
appears to be the first to shine a light on secondary metabolites gene clusters on 
Proteobacteria, Firmicutes, Spirochaetes, Tenericutes, CFB, and Fusobacteria as a 
phylum, not focusing in specific genus and/or species. 
Marine Proteobacteria have recently been in the spotlight of genome mining for 
the discovery of new bioactive molecules122–125. Despite being an abundant phylum in 
aquatic environments (50 to 80% of aquatic bacteria), few compounds have been 
described from Proteobacteria when compared to other phyla122. Among NRPs produced 
by marine Proteobacteria, indigoine and thiomarinols and have antibacterial activity; and 
myxothiazols can act as an antifungal.  
Actinobacteria is one of the most ecological diverse phyla, and that diversity can 
be observed in the variety of secondary metabolites produced126,127. This phylum is 
responsible for two thirds of the antibiotic scaffolds used in clinic today, as well as other 
bioactive compounds such as immunosuppressants, herbicides and antivirals, among 
otheres126. Multiple efforts focusing in marine Actinobacteria have been successful in 
reporting new polyketides, phenazines, isoprenoids and terpenes128–130. Resources were 
also used to mine genomes for ribosomally synthesised and post-translationally modified 
peptides116,131,132. Poorinmohamma et al. (2019) identified at least one RiPP BGC in 
25.5% of the tested genomes (n=629), totaling 477 BGCs in 185 strains131. Remarkably, 
all the subclasses of RiPPs known at the time were detected. The proportion of BGCs 
identified as RiPP in 2,186 Actinobacteria plasmids in our current study ranged from 
6.7% (deepBGC) to 3.8% (antiSMASH). This discrepancy can be explained by the total 
number of sequences used in each study, as well as the fact this study was focused on the 
plasmidome. This phylum appears to be a rich source of lanthipeptides (subclass of 
RiPPs)131,133–136, and  1163 lanthipeptide BGCs were reported in 830 actinobacterial 
genomes137.  
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Insect-associated actinobacteria also have been investigated, and case studies have 
shown the production of alkaloids, phenylpyrrolines, lanthipeptides and polyketides can 
have influence in maintaining the health of the insect and its nest138,139. Endophytic 
actinobacteria associated with medicinal plants displayed a prevalence of genes encoding 
polyketide synthases I and/or II in 33 of the 52 strains (63.46%)140. Marine actinobacteria 
isolated from Deep Sea core sediments (n=123) harbored genes for PKSs type I and/or II 
(39.13 and 56.52%, respectively) and for NRPSs (69.57%)141. While all of these numbers 
come from very specific bacterial sources and limited number of sequences, the biggest 
discrepancy when compared to the results obtained in this study is regarding NRPs. The 
detection of NRPs in this study ranged from 15.59% (deepBGC) to 21.43% 
(antiSMASH). However, the fact that the genetic space focused in this study is the 
plasmidome should be taken in consideration. 
Actinobacteria was the only phylum in which detection of alkaloid BGCs was 
observed (Table 3.3). Despite the low incidence (0.14% of BGCs classified by deepBGC), 
multiple alkaloids produced by actinobacteria have been reported. Again, the focus on 
marine Actinobacteria seems to be successful. The approach resulted in the discovery and 
characterization of anandins A and B142, actinobenzoquinoline and actinophenanthrolines 
A-C143, and unnamed alkaloids produced by Nocardiopsis sp. NCS1144. Soil 
actinobacteria are also successful producers of alkaloids, such as nonocarbolines A-E145,  
pyridine-2,5-diacetamide146, N-acetyltyramine and N-acetyltryptamine147. 
Cyanobacteria are recognized for producing a range of secondary metabolites, 
mostly NRPs and PKs, or hybrids NRP-PKs148,149. Multiple genome mining experiments 
were conducted in this particular phylum, successfully showing that it is a prolific source 
for the discovery of molecules148–153. Wang et al. (2011) reported a total of 145 BGCs 
detected in 43 genomes, mostly classified as RiPPs, as precursor peptides were 
identified148. RiPPs BGCs were also detected by Laikoski et al. (2012), in the form of 
cyanobactin pathways, in 24.6% of the genomes analyzed150. The range of RiPPs in 
Cyanobacteria detected in this study varied between 7.9% (deepBGC) and 3.7% 
(antiSMASH). Larsen et al. (2021) reported the presence of type III PKSs in 17% of the 
517 cyanobacteria genomes analyzed152. The rates of PKs observed in our study are lower 
(between 10.9 and 3.1%). However, these studies do not differentiate the gene clusters 
harbored in plasmids from the ones in the chromosome, or make it clear whether or not 
plasmids were even analyzed, so comparisons of prevalence are difficult.  
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A single study (unpublished) on the importance of plasmids in the production of 
natural products in Cyanobacteria reported at least one BGC in 17% of the total plasmids 
(n=424)154. BGCs were identified using antiSMASH. The proportion of Cyanobacteria 
plasmids with BGCs in the present study ranged from 13.36 (antiSMASH) to 33% 
(deepBGC). This difference among results can be explained by the fact that the number 
of sequences analyzed in our current study (n= 1377) is over three times that examined 
by Popin et al (2020). Regarding the classification, the presence of hybrid NRPs/PKs was 
reported to account for more than half of the gene clusters, followed by NRPs and RiPPs, 
with Terpenes being the least observed product.  While the classification of hybrid gene 
clusters was not used in this study, NRPs and PKs were the most detected class of BGCs, 
and the frequency of RiPPs and Terpenes is in agreement with what was identified by 
Popin et al. (2020). 
The use of two programs that apply different methods for BGC detection and 
classification resulted in disagreements in identification of BGCs. Machine learning 
approaches, such as deepBGC, have a bigger potential to detect novel BGCs and, 
therefore, completely new molecules155. However, a higher rate of false positives has been 
noted when compared to rule-based approaches, as is the case of antiSMASH. Hrab et al. 
(2021) analyzed the complete genome sequence of Streptomyces cyagenus S136 using an 
array of bioinfomatic tools, including antiSMASH and deepBGC156. The number of 
BGCs detected were 102 (deepBGC) and 33 (antiSMASH). Manual comparison of the 
output of all the software used revealed 41 BGC. This “control” is only achievable in a 
small sample size study, as was the case (n=1). The authors highlight that 12.5% of the 
BGCs detected were considered novel, but did not explain how the manual analysis 
agreed with the results shown by either software used. This study observed a range of 
differences between the detection and identification of BGCs by antiSMASH and 
deepBGC. As mentioned previously, deepBGC has the capacity of detecting novel BGCs, 
and that is supported by the number of gene clusters that could not be confidently 
categorized, which was over 60% across all phyla (Figure 3.2). deepBGC detected, in 
most cases, an order of magnitude more BGCs than antiSMASH (Table 3.2). This pattern 
was also observed by Yamani (2021), where the number of gene clusters detected by 






Even with the advantage of next generation sequencing (NGS), researchers 
continue to focus on the same phyla (Actinobacteria and Cyanobacteria), since it has been 
proven time and again that these are rich suppliers of bioactive molecules. However, this 
work points to bacterial plasmids across many phyla being a prolific source of 
biosynthetic gene clusters with potential bioactivity. This knowledge can be leveraged to 
focus on specific phyla of bacteria depending on the class of molecules that the research 
is focused on. The results of this work suggest that, in order to study plasmid-encoded 
RiPPs, a researcher should focus on Proteobacteria, Firmicutes, Spirochaetes and CFB 
isolates, whereas for polyketides, Actinobacteria plasmids would be more fruitful. 
Cyanobacteria and Fusobacteria plasmids would harbor more NRPs (Table 3.3). 
However, if the goal is to screen plasmids for any kind of secondary metabolite gene 
cluster, Actinobacteria showed the highest rates of plasmids harboring BGCs (Table 3.2). 
When adding the uncategorized BGCs and the higher orders of magnitude of 
detection by deepBGC, even with the chance of false positives, it seems like a fruitful 
bioinformatic approach for mining novel natural products. The fact that it also assigns 
activity of the BGC product can be leveraged to BGC-prioritization for research. 
However, antiSMASH shows a higher resolution of the classes of the BGCs detected, 
allowing the user to optimize methods for product isolation when going from the 
bioinformatic tool to the lab bench. Furthermore, it displays a percentage similarity of the 
predicted product with the products available in the antiSMASH database, which can be 





In Chapter 3, we showed by using bioinformatic tools, that the plasmidome is a 
fruitful source of molecules of interest for human and animal health. We then aimed to 
apply these bioinformatic tools in an investigation of the plasmid-encoded BGCs of 
bacteria isolated from animal-associated microbiomes.  
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In complex microbial communities, individuals can acquire and accumulate new traits 
that allow them to adjust to different conditions in their environment by sharing genes. 
Sharing plasmids, which are self-replicating extrachromosomal DNA molecules, allows 
significant exchange of genetic material and can contribute greatly to bacterial evolution. 
In light of the potential transformative role of plasmids in bacterial evolution and lifestyle, 
we purified and characterized plasmids from organisms isolated from companion 
animals, wildlife, and livestock – sources that humans encounter daily. Isolates from 
animal-associated microbial communities were screened for the presence of plasmids: 
cat-associated microbial community (n=50), Escherichia coli isolated from wild birds 
(n=65) and isolates from bovid-associated microbiomes (n=250). At least one plasmid 
was detected in 47/50, 36/65 and 38/250 of these isolate collections, respectively. 
Phenotypic screening was done for the plasmids recovered from wild bird isolates, and 
plasmid-encoded antibiotic resistance was detected in seven isolates. The taxonomic 
identity of plasmid-harboring strains from bovid-associated microbiomes was determined 
using the 16S rRNA gene and showed that most of the identified plasmid harboring 
isolates were Gram-positive. Apart from K. pneumoniae, all isolates belong to the phylum 
Firmicutes. Twelve plasmids from seven host isolates were chosen to be sequenced and 
three plasmids (pRAM-12, pRAM-19-2 and pRAM-30-2) shared 100% nucleotide 
sequence identity. Curiously, two of the parent strains shared more than one plasmid in 
common, despite being in different phyla: pRAM-19-1 and pRAM-30-1 were also 
identical. Host RAM-19 was identified as K. pneumoniae, a Proteobacteria; and RAM-
30 as B. licheniformis, a Firmicute. pRAM-28 from S. aureus contained genes encoding 
the bacteriocin aureocin A70; and pRAM-21 has 100% nucleotide identity to pRAM-28. 
Additional analysis of sequences of plasmids from the bovid isolate collection resulted in 
the detection of three other bacteriocins: cloacin and two putative gene clusters for 
lanthipeptides. The results of this work suggest that the plasmidome is an important 
source of potential unknown secondary metabolites that are used by bacteria to compete 
with each other within and between microbiomes. Genetic exchange and the apparent 






It is well known that the interface between humans, domestic animals, wildlife 
and the environment influences the health status of all living beings involved. This 
interface has been entangled in the emergence of infectious diseases and new and re-
emerging zoonoses158,159. Changes to the food production system and closer contact with 
companion animals can explain the increase of animal-borne zoonoses, since there is 
increased opportunity for direct transmission with and without vectors160. However, by 
approaching animals as a host-microbe ecosystem, we can develop new insights into the 
maintenance of human health, especially by recognizing that the interaction between 
bacteria and other organisms are central for the health status of both the individual and 
the environment161. Although the role of individual bacteria in infectious disease has been 
studied since the nineteenth century, research on microbiomes and their roles in 
prevention, cause or aggravation of diseases only began in the recent decades162.  
Microbiomes are defined by their bacterial membership and environmental niche. 
A common feature of microbiomes is functional redundancy among their members1,2. 
There are two major paths to this redundancy: recruitment of bacteria that share traits or 
trait sharing between bacteria. Specific recruitment implies a long, well-established 
system that has co-evolved. Trait-sharing among bacteria can happen on a much shorter 
timescale. The latter is facilitated by interactions between individuals within a 
microbiome via horizontal gene transfer (HGT), which allows for the acquisition and 
accumulation of new adaptive traits that reflect their environment. Among the known 
mechanisms of HGT, plasmid exchange is one that allows for rapid transformative effects 
from the acquisition of large gene collectives. A plasmid can drastically alter an 
individual’s phenotype. Their acquisition has been correlated to the development of 
antibiotic resistance24,163,164, virulent phenotypes13,15,165,166, and iron-scavenging 
molecules17,18.  
Nearly all plasmidomic studies are simply nucleotide sequence-based 
metagenomics8,9. This results in knowledge of plasmids regardless of host bacteria. In 
contrast, the functional annotation of plasmid-encoded genes has typically been done by 
studying the genes or gene clusters on a case-by-case basis rather than through the 
prioritization of this genetic space. More often than not, these functional studies are not 
focused on plasmid-encoded traits and this genomic context is a chance finding, not the 
emphasis of the study. As a result, plasmid-encoded traits have been revealed on a 
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plasmid-by-plasmid basis rather than attempting a systematic approach that prioritizes 
plasmid isolation and functional annotation through phenotypic screens prior to 
nucleotide sequencing. Therefore, the objective of this project was to prioritize this 
genetic space. We purified and characterized plasmids from known bacterial isolates 
isolated from animal-related microbiomes. We focused on plasmids from microbial 
communities that have the greatest potential to influence our own microbiomes, those 
with overlapping environment and that are associated with companion animals, wildlife 
and livestock. From our samples from dairy and beef cattle in Saskatoon, Saskatchewan, 
we re-discovered a four-membered bacteriocin system that was originally described from 
Staphylococcus aureus isolated from milk in Brazil; two putative gene clusters for 
lanthipeptides; as well as a cloacin gene cluster. Our results show that a prioritization of 
the plasmidome along with a systematic evaluation of plasmids from related microbiomes 




4.3 Materials and Methods 
 
4.3.1 Bacterial isolation and growth 
 
Escherichia coli isolated from wild birds 
 
 A collection of Escherichia coli isolated from wild birds was donated by the Rubin 
Lab. Sixty-five crows (Corvus brachyrhynchos) that were taken to the Veterinary Medical 
Center at the University of Saskatchewan had swabs from their cloacas. Swabs were 
plated on chromogenic extended-spectrum beta-lactamases (ESBL) agar and incubated at 
37 ºC overnight. This agar allows for the selective isolation of ESBL-producing isolates, 
with  high sensitivity and specificity, based on color difference167,168. E. coli presents itself 
in a dark pink to reddish color. These colonies were re-streaked on Columbia Blood Agar 
(5% sheep’s blood) at 37 °C overnight. For plasmid screening and purification, the 




Fifty isolates obtained from cat feces were received from Dr. Ruzzini. The media 
used for bacterial isolation were R2A and Brain Heart Infusion (full-strength or 1∕10). For 
isolation experiments, samples were plated and incubated at 30 °C. After growing the 
isolates in liquid broth, monocultures were verified by re-streaking single colonies, using 
the same medium that was used for isolation. For plasmid screening and isolation 
experiments, the isolates were grown in 50 mL of the same medium used for isolation, 




Bacteria were isolated from five distinct bovid-associated microbiomes: dirty and 
clean bedding from a dairy barn, milk and teat canal swabs of dairy cattle, and bovine 
feces (beef and dairy cattle). The milk and mammary swabs were collected from both 
healthy and mastitic cattle. This work was designed and conducted in accordance with 
the Canadian Council for Animal Care and approved by the University Animal Care 
Committee at the University of Saskatchewan (Protocol Nº AUP20080015). Three 
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distinct media were used for bacterial isolation: R2A and 1/10 Brain Heart Infusion 
supplemented with cyclohexamide (200 g/mL), or Columbia Blood Agar (5% sheep’s 
blood). For isolation experiments, serial dilutions of samples were plated and incubated 
at room temperature, 30 ºC and 37 ºC. Single colonies were picked from isolation plates 
to generate monocultures. Morphological diversity was used to prioritize colony selection 
for further propagation. Monocultures were verified by re-streaking single colonies that 
were picked and grown in liquid broth, typically the same medium that was used for 
isolation but without the addition of the antifungal agent (cyclohexamide).  
For plasmid screening and purification experiments, the isolates were cultivated 
in 50 mL LB overnight, at 200 rpm and 37 ºC. For more fastidious organisms, tryptic soy 
broth supplemented with additional yeast extract (3 g/L) was used for bacterial 
propagation.  
 
4.3.2 Plasmid screening and purification  
 
All the isolates were grown in 50 mL cultures. After harvesting the cells by 
centrifugation, the pellet was subjected to an alkaline lysis169,170. Briefly, the pellet was 
resuspended in 4 mL of solution I (10 mM Tris-HCl, 1mM EDTA pH 8.0) containing 10 
g/mL of RNase A. After full resuspension, 6 mL of solution II (0.2 M NaOH, 1% sodium 
dodecyl sulfate) was carefully added and mixed by inversion. 8 mL of solution III (3 M 
potassium acetate) was used to neutralize the mixture. The addition of solution III was 
followed by careful inversion and an incubation on ice for 15 minutes. After another 
centrifugation at 20627 × g, 4 ºC for 10 minutes, the supernatant was mixed with one 
volume of cold isopropanol and kept at –20 ºC for two hours. Following the incubation 
time, the DNA was pelleted by centrifugation at 20627 × g, 4 ºC for 30 minutes. The 
supernatant was discarded and the pellet washed with ethanol twice. After centrifuging 
again, for the removal of the ethanol, the pellet was air-dried. The dry DNA pellet was 
resuspended in 50-100 L of TE buffer (10 mM Tris-HCl, 1mM EDTA pH 8.0). 250 ng 
of the obtained DNA were loaded on a 0.8% agarose gel with ethidium bromide for 
analysis. Isolates that harbored plasmids were grown at a larger scale (200 mL) and 
plasmids were purified using a commercial kit (PureLinkTM, HiPure Plasmid Midiprep 
Kit, Invitrogen®) for better yield and purity. 
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4.3.3 Phenotypic screening plasmids from wild bird E. coli isolates  
 
A plasmid-encoded phenotypic screening pipeline (Figure 4.1) was developed and 
applied to the E. coli isolate collection from wild birds. First, chemically competent 
NEB® 5α competent E. coli (New England Biolabs, Whitby, ON) was transformed with 
pools of purified plasmids. Pools of five plasmids were created, using 50 ng of each 
plasmid. After pooling, the mixture was dried by speed vacuum and resuspended in 10 
μL of TE buffer. A 50 μL aliquot of chemically competent E. coli cells was thawed on 
ice and 3 μL of the plasmid pool was added into the vial and mixed gently by tapping. 
The mixture was incubated on ice for 30 minutes and heat-shocked in a 42 °C water bath 
for 30 seconds. Another ice incubation for five minutes was done before adding 950 μL 
of room-temperature LB. This was followed by an incubation at 37 °C for 1 hour at 200 
rpm in a shaking incubator. After the incubation period, 100 μL of cells were spread on 
LB agar plates supplement with kanamycin (50 µg/mL), ampicillin (100 µg/mL), 
chloramphenicol (40 µg/mL), tetracyline (25 µg/mL), and sulfamethoxazole (20 µg/mL). 
The plates were incubated at 37 °C overnight before being accessed for growth. Plates 
that presented growth had the plasmids from the pools transformed individually, to 
associate plasmids with the observed phenotype.  
Plasmids that did not have a natural antibiotic resistance gene had in vitro 
transposon insertions of an antimicrobial resistance cassette, in order to construct 
plasmids that could be propagated in E. coli163,171–173. By using a transposase, we were 
able to insert a kanamycin (kanR) resistance marker randomly into the plasmid DNA. The 
reaction was set up with 1 µL of EZ-Tn5 10X Reaction Buffer, 0.2 µg of target DNA and 
the molar equivalent of EZ-Tn5 Transposon, 1 µL of EZ-Tn5 Transposase (1 U) and 
sterile water to a reaction volume of 10 µL. The mixture was incubated at 37 °C for two 
hours. The addition of 1 µL of EZ-Tn5 10X Stop Solution was followed by incubation at 
70 °C to stop the reaction. 
Chemically competent NEB® 5α competent E. coli was transformed using 5 µL 
of the insertion reaction. The transformation was done as previously described. After the 
incubation period, 100 μL of cells were spread on LB agar plates with kanamycin (50 
µg/mL). The plates were incubated at 37 °C overnight. To construct the transposon-aided 
capture (TRACA) library, 192 colonies were randomly picked from the plates and used 
to inoculate two 96-well plates. Each well contained 200 μL of LB plus kanamycin. The 
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plates were incubated at 37 °C overnight with shaking at 200 rpm. This library was used 








In order to identify the production of a broad range of pathogenic effectors, we 
used an assay inspired by a naturally occurring interaction in the soil: the predator-prey 
relationship between amoeba and bacteria. The amoeba Dictyostelium discoideum 
requires bacteria as a food source. Consumption of edible bacteria (bacteria that do not 
produce any virulence factors) leads to the development of macroscopic fruiting bodies, 
while inedible bacteria (isolates expressing virulence factors) prevent amoebal growth. 
The co-cultivation of amoeba and bacteria has been done to identify pathogens174 and as 
a starting point for the discovery of small molecules175,176, since amoeba toxicity is a 
proxy for toxicity to other eukaryotes. The TRACA library was used as a food source. 
After growing the bacterial library for 6 hours, 5 μL of each isolate were spotted on SM/5 
agar (per liter: 2 g glucose, 2 g bacto peptone, 0.2 g yeast extract, 0.2 g MgSO4∗7H2O, 
1.9 g KH2PO4, 1.0 g K2HPO4, and 15 g agar). A suspension containing an axenic culture 
with 7 x 104 cells per mL of D. discoideum cells was spotted (5 μL) on top of the dry 
bacterial food source spots. The plates were incubated at room temperature for 48 hours 
and the presence or absence of amoeba growth on each spot was assessed visually. 
Iron is an essential element for the growth of bacteria and is often correlated to 
pathogenesis. Siderophores are small molecules that scavenge iron from the host or the 
environment 177. Siderophore production was monitored by spotting 10 L of each isolate 
from an overnight culture of TRACA library on a nutrient agar containing chrome azurol 
S (CAS), iron (III) and hexadecyltrimethylammonium bromide178. These components 
form a complex that is disrupted by siderophore activity, resulting in colour change from 
blue to orange. Plates were incubated at 37 °C overnight before being assessed for colour 
change. 
To detect plasmid-encoded antimicrobial production, we used an assay that has 
been successfully implemented to identify biologically active small molecules from 
cosmid libraries 179–181. The E. coli clones from the TRACA library were spotted on LB 
agar plates containing kanamycin and incubated at 37 °C overnight. A thin layer of soft 
agar (0.4%) containing an intruder bacterium is overlaid. E. coli harboring the plasmid 
pET-41 was used as an intruder, since this plasmid confers kanamycin resistance to its 
host. The clones that have the ability of producing antimicrobial molecules were 
identified after incubation at 37 °C, by the inability of the intruder strain to grow nearby, 




4.3.3 Isolate identification  
 
The taxonomic identities of isolates that harbored plasmids were determined by 
16S rRNA gene sequencing. The PCR was carried out using universal primers 8F (5’-
AGA GTT TGA TCC TGG CTC AG-3’) and Eub1492R (5’-ACG GCT ACC TTG TTA 
CGA CTT-3’). Each PCR reaction (50 μL) contained 1X Dream Taq Buffer (proprietary 
buffer that contains KCl, (NH4)2SO4 and MgCl2), 0.2 mM dNTP, 0.3 μM of each primer, 
approximately 500 ng of template DNA, and 5 U of Dream Taq (ThermoFisher, Waltham, 
MA). The thermocycler parameters were: 95 °C for 5 minutes, followed by 30 cycles of 
denaturation at 95 °C for 30 seconds, annealing at 50 °C for 30 seconds, extension at 72 
°C for 90 seconds, and final extension for 5 minutes.  
PCR products were visualized on a 0.8% agarose gel, and purified using QIAquick 
PCR Purification Kit (Qiagen, Mississauga, ON). The Sanger sequencing of the PCR 
amplicons was done by Macrogen, Korea. An 800 bp region of each gene sequence was 
used as a blastn query of the NCBI 16S Microbial database.  
 
4.3.4 Plasmid sequencing, de novo assembly and annotation 
 
Plasmid DNA libraries were prepared using Nextera DNA Flex Library Prep kit 
(Illumina) according to the manufacturer’s instructions and sequenced using an Illumina 
iSeq-100 at the University of Saskatchewan Next-Generation Sequencing Facility. Paired 
end reads were assembled into contigs using Geneious software182, applying default 
settings. Contigs with one order of magnitude higher coverage than the rest (suggestive 
of plasmid derived contigs) were annotated through Rapid Annotation using Subsystem 
Technology (RAST). Manual analysis of the annotations, repeated sequences and protein-
coding genes were used generate circular plasmid DNA sequences. The plasmid 
sequences were analyzed with antiSMASH and deepBGC as well, to identify potential 






4.4.1 Plasmid screening 
  
A total of 365 bacterial isolates from animal microbiomes were screened for 
plasmids. At least one plasmid was identified in 121 isolates. The cat related collection 
had 94% (47/50) of the isolates harboring at least one plasmid. The bovid-associated 
microbiome collection plasmid screen resulted in 15.2% (38/250) of isolates, while 55.3% 
(36/68) of the E. coli collection from wild birds harbored plasmids. 
Plasmids were purified from each isolate, and twelve plasmids from bovid-
associated isolates were deliberately chosen for sequencing. These were prioritized based 
on bacterial source, bacterial species, and differences between their apparent size when 
visualized using ethidium bromide-stained agarose gels. We explicitly included plasmids 
from two prominent pathogens in our study. One from Staphylococcus aureus was 
included, since this pathogen is a priority for Canadian Dairy industry stakeholders183. A 
second from Klebsiella pneumoniae was selected, since it was the most prominent 
infectious agent in the barn during the collection period of spring and summer of 2019. 
Another main factor when choosing the plasmids to be sequenced was the fact that they 
appeared smaller than the expected average plasmid size. 
 
4.4.2 Phenotypic screen 
 
Plasmids from 36 E. coli isolates recovered from C. brachyrhynchos were pooled 
and used to transform chemically competent E. coli. The transformants were plated on 
LB plates containing different antibiotics, in order to screen for antibiotic resistance. 
Pools that contained resistant transformants had their plasmids transformed individually 
to associate phenotype with plasmid.    
Plasmid-encoded antibiotic resistance was observed in seven cases. In four 
instances, plasmids mediated resistance to two antibiotics, ampicillin and tetracyline. 
Resistance to ampicillin only was observed in one case, while resistance in tetracyline 
exclusively was detected in two circumstances. In all seven cases, it allowed for growth 
in sulfamethoxazole (Table 4.1).  
A library composed of 192 TRACA transformants was screened for the 
phenotypes of interest (antibiotic resistance, virulence factors, and small molecule 
 64 
production). None of the transformants presented these phenotypes, indicating that the 




Table 4.1: Antibiotic resistance conferred by plasmids purified from seven E. coli isolates 
from wild birds (C. brachyrhynchos). 
Source isolate Ampicillin Tetracycline Sulfamethoxazole 
106A  + + 
107A +  + 
112A + + + 
113A + + + 
114A + + + 
115A + + + 





4.4.3 Host isolate identification 
 
The taxonomic identity of plasmid-harboring strains from cat feces and bovid-
associated microbiomes was determined using 16S rRNA gene sequences. Taxonomy 
classification was deemed successful when over 98% identity was detected. The 16S 
rRNA gene identification showed that the vast majority of the identified plasmid 
harboring isolates from bovid-associated microbiomes are Gram-positive (Table 4.2). 
Apart from Klebsiella pneumoniae, all the known isolates belong to the phylum 
Firmicutes (97.1% of isolates), with the genus Bacillus composing the majority of 
isolates. This trend was also observed in the cat-associated microbiota, where 15/24 
(62.5%) of the identified isolates belonged to the Firmicutes phylum. However, the 
majority of these isolates belonged to the genus Staphylococcus. The remaining 37.5% 
were part of Proteobacteria and, more specifically, belonged to the class 
Gammaproteobacteria. 
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Table 4.2: Taxonomic ID of plasmid-harboring isolates from feline- and bovid- associated 
microbiomes. 
Source Isolate ID 
Cat 
Salmonella enterica (n=1) 
Escherichia fergusonii (n=1) 
Enterococcus faecalis (n=4) 
Staphylococcus epidermidis (n=10) 
Streptococcus canis (n=1) 
Pseudomonas viridiflora (n=1) 
Escherichia coli (n=6) 
Dairy cattle 
Staphylococcos sciuri (n=1) 
Bacillus licheniformis (n=13) 
Bacillus rhizospherae (n=1) 
Bacillus pumilus (n=6) 
Bacillus pervagus (n=2) 
Bacillus subtilis (n=1) 
Lysinibacillus fusiformis (n=1) 
Bacillus circulans (n=1) 
Staphylococcus auricularis (n=2) 
Lysinibacillus pakistanensis (n=1) 
Staphylococcus equorum (n=2) 
Klebsiella pneumoniae (n=1) 
Staphylococcus aureus (n=1) 




4.4.4 Plasmid sequencing, de novo assembly and annotation 
 
Sequencing of 13 plasmids from the bovid microbiome isolates was done using 
paired-end Illumina technology. The average number of reads/sample was 371,248. After 
assembling the reads into contigs, the mean coverage was used to determine which 
contigs were possibly plasmids. Contaminating genomic DNA was present in all samples 
although as expected, coverage was much lower for these contigs. Contigs with a mean 
coverage that was at least one order of magnitude higher than that of the majority of 
sequences in the dataset were selected for bioinformatic annotation using RAST. Manual 
inspection of the contigs revealed repetitive sequences, which was used define their 
circular nature. The annotated plasmids are described in Table 4.3.  
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Table 4.3: Plasmids assembled in this study. 
Host Plasmid Size (bp) Average coverage 
Bacillus licheniformis (RAM-2) pRAM-2 27,419 1,063 x 
Bacillus pumilus (RAM-4) pRAM-4 7,143 871 x 
Bacillus pumilus (RAM-9) pRAM-9 4,299 66 x 
Bacillus licheniformis (RAM-12) pRAM-12 5,723 144 x 
Staphylococcus auricularis (RAM-15) pRAM-15 7,497 815 x 
Klebsiella pneumoniae (RAM-19) 
pRAM-19-1 4,399 244 x 
pRAM-19-2 5,723 151 x 
pRAM-19-3 7,819 127 x 
Staphylococcus auricularis (RAM-21) pRAM-21 8,245 95 x 
Staphylococcus aureus (RAM-28) pRAM-28 8,052 310 x 
Bacillus licheniformis (RAM-30) 
pRAM-30-1 4,399 313 x 
pRAM-30-2 5,723 140 x 




Plasmid pRAM-2 (Figure 4.2A) was analyzed with antiSMASH and deepBGC. 
Both identified a RiPP biosynthetic gene cluster although the results from the two 
programs differed. While antiSMASH classified all of the genes as belonging to a single 
cluster, deepBGC detected only the second gene cluster. Manual analysis of the predicted 
protein sequences showed that the pRAM-2 plasmid has two putative class II 
lanthipeptide BGC. The first gene cluster (Figure 4.2B) is composed of (i) a gene that 
encodes for the 71 amino acid lanthipeptide precursor; (ii) lanM, an enzyme that contains 
regions responsible for Ser and Thr dehydration in the N-terminal domains, whereas the 
C-terminal region catalyses the lanthionine bridge formation26; (iii) a serine peptidase 
coding sequence; and (iv) a predicted ABC transporter that expels the mature peptide out 
of the cell. The precursor peptide shares 100% sequence similarity in its last 54 amino 
acids to a lanthipeptide produced by Mammaliicoccus sciuri that belongs to the 
LchA2/BrtA2 family (Accession number WP_199194657.1).  
The second putative lanthipeptide gene cluster (Figure 4.2C) contains (i) a gene 
responsible for the 63 amino acid lanthipeptide precursor; (ii) lanM, a modification 
enzyme; (iii) putative ABC transporter; and (iv) ABC transporter permease CDS, both 
part of the efflux system to transport the active peptide to the surrounding environment. 
The lanthipeptide produced shares 98.4% nucleotide similarity with a lanthipeptide from 
the plantaricin C family, curiously also produced by M. sciuri (Accession number 
WP_107602421.1). When aligned with the plantaricin C lanthibiotic (Accession number 
WP_064511516.1) produced by Lactobacillus plantarum, only 32.8% nucleotide 
similarity was observed. Manual annotation of the rest of plasmid pRAM-2 resulted in 
identification of other coding sequences that are not involved in specialized metabolite 
production (Table 4.4).  
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Figure 4.2: Plasmid pRAM-2 (A) harbors two putative lanthipeptides gene clusters (shown in green and blue). Genes responsible for partition and 
replication are shown in purple. Displayed in pink are other known CDS. Genes with unknown functions are dark grey. The first BGC (B) is 
responsible for the production of a lanthipeptide that shares 100% nucleotide sequence in the region that overlaps with a previously identified 
LchA2/BrtA2 family lanthipeptide. Genes responsible for the modification enzyme LanM, serine peptidase and transport protein are also part of 
this BGC. The second lanthipeptide gene cluster (C) has as a product 98.4% similarity with a plantaricin C family lanthipeptide of M. sciuri, a 
LanM post-translational modification enzyme and genes responsible for the transport protein. 
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Table 4.4: Plasmid pRAM-2 coding sequences that are not involved in secondary 




1405 1920 Transcription factor regulator 
1917 2276 Adenylyltransferase 
6471 4630 ATP-dependent endonuclease 
7650 7093 Resolvase/integrase 
8707 7874 Methyltransferase 
9774 8779 Histidine kinase 
10445 9780 Transcription factor regulator 
22575 22324 Plasmid replication associated protein 
23367 22576 Partition protein A 
24025 25050 Replication initiation protein A 
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Curiously, two of the parent strains share more than one plasmid in common, 
despite these hosts being in different phyla: RAM-19 was identified as K. pneumoniae, a 
Proteobacteria; and RAM-30 as B. licheniformis, a Firmicute. Nonetheless, pRAM-19-1 
(Figure 4.3A) and pRAM-30-1 have 100% consensus identity (Figure 4.3B). However, 
no biosynthetic gene cluster was identified in pRAM-19-1. Apart from the genes involved 
in mobilization and replication, gene functions were unknown.  
Plasmids pRAM-12, pRAM-19-2 and pRAM-30-2 were also found to be identical 
to each other (Figure 4.3C and D). These plasmids all harbor a gene cluster responsible 
for the production, immunity and export of cloacin (Figure 4.3E), identified manually. 
The cloacin peptide encoded by these plasmids shares 100% amino acid identity with the 
peptide produced by several species of Enterobacteriaceae (Accession number 
WP_101972327.1) (Figure 4.3F). This gene cluster was first described in 1969184, 
observed in Enterobacter cloacae harboring the plasmid CloDF13 and its composed by 
(i) cloacin peptide; (ii) immunity protein185; and (iii) cloacin release. Interestingly, this 
BGC was identified in diverse Proteobacteria, and similar gene clusters (with over 92% 
identity) were detected in Firmicutes, when compared to the non redundant protein 
database.  
Plasmids pRAM-4, pRAM-9, pRAM-15, pRAM-19-3 and pRAM-30-3 (Figure 
4.4) had few genes with known functions. Unknown genes represented from 42.9 
(pRAM-19-1) to 100% (pRAM-9) of the genes on the plasmids. Identified coding 
sequences and their predicted functions, as well as the percentage of unknown genes, are 




Figure 4.3: Plasmid pRAM-19-1 (A) shares 100% nucleotide sequence with the plasmid pRAM-30-1(B), despite hosts belonging to different phyla. 
Plasmid pRAM-19-2 (C) shares 100% nucleotide identity to plasmids pRAM-12 and pRAM-30-2 (D). These plasmids harbor a biosynthetic gene 
for the production, immunity and export of cloacin (E). The cloacin produced has 100% identity to the cloacin produced by members of the 
Enterobacteriaceae (F). Genes in purple are responsible for mobilization and replication, and genes in grey are unknown.  
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Figure 4.4: Plasmids reassembled in this study that did not harbor known BGCs. Genes in purple are responsible for mobilization and replication. 
Pink colored genes are genes that were identified but are not involved in known gene clusters. Genes in grey are unknown.
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% of genes with 
products of 
unknown identity  
From To 
pRAM-4 
67 468 Plasmid replication 
68.8 
1516 1665 Plasmid replication 
4910 6028 Aspartate phosphatase 
6018 6134 Rap protein 
6509 7534 Plasmid replication 
pRAM-9  - - - 100 
pRAM-15 
1847 3337 Replication initiation protein A 
71.4 
6073 5399 IS6 family transposase 
pRAM-19-1 
1497 1 Relaxase 
42.9 
1862 1494 Mobilization protein C 
3246 4112 Replication initiation protein 
4116 4391 Plasmid replication 
pRAM-19-3 
777 385 IS3 family transposase 
46.7 
768 1520 IS3 family transposase 
2662 1997 Replication initiation protein 
3121 2927 IS1 family transposase 
4700 3813 Integrase 
6078 5968 Small membrane protein 
6556 7059 Transposase 
7146 319 Acyltransferase 
pRAM-30-3 
1318 1863 Integrase 
87.5 
3302 2886 Lipase 
8935 9162 Transcription regulator 
14688 15653 Integrase 
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The plasmid isolated from S. auricularis (pRAM-21) was identical to the plasmid 
isolated from S. aureus, pRAM-28 (Figure 4.5A). Both of these plasmids share 89% 
nucleotide sequence identity with plasmid pRJ6, a plasmid from S. aureus that is 
notorious for harboring the only known four-member bacteriocin gene cluster186. 
Production of these peptides, collectively referred to as aureocin A70, is the hallmark 
feature of pRJ6 and now pRAM-21 and pRAM-28. However, this BGC was only detected 
through manual annotation.  
The A70 BGC (Figure 4.5B) is composed of (i) aurR, a regulator187; (ii) aurI, that 
encodes for a protein that gives the host strain immunity188; (iii) the aurABCD operon, 
composed of four genes that code for individual peptides that form the bacteriocin; and 
(iv) aurT, an ABC transporter responsible for the efflux of the bacteriocin outside of the 
cell186. The nucleotide sequence similarity shared among the presumed operon aurABCD 
from pRJ6 and the operon from the plasmids isolated in this study is 99.8%. A non-
synonymous mutation within the aurD coding sequence is the only difference among 
them (Figure 4.5C). The mobilization genes found on both of the plasmids were 
substantially more divergent, sharing 78.9% nucleotide sequence identity with their 
orthologous sequences on pRJ6.  
A bioinformatic search for aureocin A70 outside of South America was performed 
using the Basic Local Alignment Search Tool (BLAST)189. Sequences similar to the 
aureocin A70 gene cluster were identified, including eight matches between 99 and 
99.94% identity at the nucleotide level. Three were isolated in Brazil, two from bovid-
microbiome (Accession numbers AF241888.2 and MK796167.1), and one from a human 
case of meconium aspiration syndrome (Accession number CP021143.1). One isolate 
from a human in Germany was also a match, but no further information was available 
(Accession number CP047834.1). The other four were all isolated in the United States, 
three in a Methicillin-Resistant Staphylococcus aureus (MRSA) outbreak in a New York 
city/state hospital (Accession numbers CP030522.1; CP030402.1; CP030460.1), and one 
is present in the Food and Drug Administration’s Center for Disease Control 
Antimicrobial Resistant Isolate Bank (Accession number CP029651.1).
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Figure 4.5: Plasmid pRAM-21 and pRAM-28 (A) share 100% nucleotide identity. These plasmids carry a BGC that is responsible for the regulation, 
production, immunity and transport of aureocin A70 (B), previously detected on plasmid pRJ6. The only difference between the gene cluster 





Table 4.6: Coding sequences with known function from plasmid pRAM-28 that are not 




1216 401 Mobilization protein B 
1925 918 Relaxase 
2290 1907 Mobilization protein C 





The acquisition or loss of a plasmid can drastically alter a bacterium’s phenotype. 
However, plasmids are rarely the target of microbiome research. In this study, we focused 
on the plasmidome of microbiomes that often overlap and can influence our own 
microbiome. By using a combination of phenotypic and genomic methods, phenotypes of 
interest for both human and animal health, in the form of antibiotic resistant genes, were 
detected. Secondary metabolites gene clusters were identified, and evidence of plasmid 
sharing among phyla was observed. 
Plasmids isolated from E. coli (n=36) recovered from wild crows (C. 
brachyrhynchos) that were brought to the Veterinary Medical Center at the University of 
Saskatchewan were screened for phenotypes of interest. Although no siderophore or 
antimicrobial activities were observed, resistance to three classes of antibiotics: β-
lactams, tetracyclines and sulfonamides, was encoded by 19.4% (n=7) of the plasmids 
(Table 4.1). All seven of these plasmids harbored antibiotic resistance genes for 
sulfonamides. Although chromosomal variants of the folP gene result in sulfa resistance, 
the majority of clinical resistance is plasmid-borne190. Currently, four genes (sul1-4) are 
known to result in sulfonamide resistance, although only three (sul1-3) of them have been 
identified in clinical settings. Over eighty-five years of use of sulfa drugs, as well as the 
large presence on plasmids reported results in no surprise that all the plasmids that showed 
antibiotic resistance phenotype carried one of the sul genes.  
Five and six of the plasmids from wild bird E. coli also resulted in ampicillin and 
tetracycline resistance of host bacteria, respectively, with four plasmids conferring 
resistance to all three antibiotics. Plasmid-mediated resistance to ampicillin arises from 
the production of β-lactamases, enzymes that hydrolyze the β-lactam ring, rendering the 
antibiotic inactive164,191,192. Over 2000 unique β-lactamases have been reported in 
different settings191,193. Both the fact that β-lactamases coding sequences are largely 
encoded in plasmids and mobile elements across a myriad of Enterobacteriaceae, as well 
as their high adaptability to expand their activity spectrum as new modified antibiotics 
are introduced, are decisive for the success of the spread of these genes and a threat to the 
effectiveness of β-lactams194,195. Tetracycline resistance was first reported in 1953196,197 
and became largely associated with the presence of plasmids and other mobile genetic 
elements196,198,199. Three different methods of tetracycline resistance have been identified: 
efflux of tetracycline by energy dependent membrane associated proteins, ribosome 
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protection proteins and enzymatic alteration of the drug. Tetracycline efflux from the cell 
is the most common mode of resistance acquired by bacteria196,199–202, with 26 genes 
responsible for transmembrane efflux pumps identified. Of those, at least 14 are plasmid-
encoded202. Future sequencing work can be done to determine which genes are at play in 
the resistance phenotype observed in wild bird E. coli, as well as to contribute with the 
knowledge of which genes are circulating in the environment. 
Four of the plasmids purified and screened in this section of the work encoded for 
resistance to three antibiotics (Table 4.1). Multidrug resistance plasmids have been 
identified in Enterobacteriaceae isolated from avian sources in different settings. When 
studying E. coli isolated from wild and domestic birds in Bangladesh, Hasam et al. (2012) 
observed that resistance to tetracycline, trimethoprim/sulfamethoxazole and ampicillin 
had the highest incidence among isolates203. Both Ahmed et al. (2013)204 and Enany et al. 
(2019)205 analysed E. coli isolates from septicemic broilers and  environmental and avian 
sources, from Egyptian farms, respectively. All (100%) of the tested isolates in both 
studies were resistant to ampicillin and tetracycline, among other antibiotics tested. The 
first study observed resistance in all isolated to the combo 
trimethoprim/sulfamethoxazole, while the second study reported resistance to 
sulfamethoxazole in 80.92% of the isolates. Similar trends of resistance were also 
observed in avian pathogenic E. coli responsible for colibacillosis in poultry farms in 
Pakistan206,207 and in an outbreak of multidrug resistant pathogenic E. coli in canaries, in 
Brazil208.  
Although the screening process did not result in sequencing to associate genes 
with the resistance phenotype observed, this approach allows us to maintain the 
connection of host and plasmid, which does not occur in metagenomic approaches. This 
link is of relevance because it provides information relevant in two aspects: first, knowing 
what genes are circulating in determined non-pathogenic, commensal microbiota allows 
us to infer what pool of traits is available to be picked up by pathogens interacting with 
that community. Secondly, when determined to have antibiotic resistance genes in 
pathogenic bacteria, it provides us with a much more urgent scenario that required careful 
considerations. The same can be said if a virulent phenotype were detected in a previously 
non-pathogenic bacterium. 
The high incidence of plasmid-mediated antibiotic resistance in E. coli isolates 
obtained from birds, both observed in this study (19.4%) and in the literature suggests 
that the use of antibiotics is selecting the phenotype of resistance further from human and 
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veterinary clinical use. It also indicates that wild birds could be used for surveillance of 
spread of resistance, as suggested by Parker et al. (2016)209. 
Since the phenotypic screen conducted in the first part of this study demonstrated 
the utility of the culture-based approach used for the identification plasmids that can be 
screened systematically for interesting phenotypes, plasmids were purified from feline 
and bovid microbiomes and we investigated the distribution of these plasmids across 
phyla, as well as the presence of biosynthetic gene clusters.  
Domestic cat fecal isolates carrying plasmids belonged to the phyla Firmicutes 
(62.5%) and Proteobacteria (37.5%). This is in accordance with previous descriptions of 
feline fecal microbiomes, although it is important to highlight that only plasmid-harboring 
isolates were taxonomically identified in this study. Other studies of the feline fecal 
microbiota identified Firmicutes in a range of 13 to 92% of the microbiota, followed by 
Proteobacteria (6-14%) and Actinobacteria (7%)210–213. The differences among the results 
of these studies is not only influenced by method and feline individual, but also by age214, 
diet215, obesity and whether or not the animal is neutered216. 
Regarding the plasmid-harboring isolates from bovid-associated microbiomes, 
the most abundant phyla is Firmicutes (97.1%). Herbivore gut microbiota has, reportedly, 
an abundance of Firmicutes bacteria217–219, which can also be observed in the rumen 
microbiota219. The high incidence of Firmicutes plasmids purified from Bacilli was also 
observed by Shintani et al (2015), when analyzing plasmid sequences available on NCBI 
database220.  
 Twelve plasmids from bovid-associated isolates were selected for sequencing, and 
the plasmids reassembled are shown in Figures 4.2-5. Software designed for the detection 
of BGCs (deepBGC and antiSMASH) was only successful in identifying gene clusters in 
the case of pRAM-2, and manual annotation was necessary to resolve differences in their 
results. Manual annotation was used to assign BGCs in the other plasmids. This resulted 
in the identification of a cloacin gene cluster in three plasmids from different hosts, as 
well as the detection of aureocin A70 gene cluster in two other plasmids. The cloacin 
gene cluster appears to be widespread in bacteria.  
Plasmids pRAM-21 and pRAM-28 harbor a BGC responsible for the production 
of aureocin A70. This bacteriocin system was initially described in Staphylococcus 
isolates from milk in Brazil186. Further studies by the same group suggested a broader 
geographical range of this biosynthetic gene cluster in South America, more specifically 
in cows suffering from subclinical mastitis from Argentinian herds221. Bacteriocins 
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identical or similar to aureocin A70 were also present in 34 strains involved in bovine 
mastitis in southeast Brazil222. When screening staphylococci isolates from milk of 
healthy cows in Brazil for bacteriocin production, Brito et al. (2011) determined that 58 
of 111 isolates provided PCR products when primers for the aureocin A70 gene cluster 
were used223. This suggests that the presence of bacteriocin is not exclusive to clinical 
cases of mastitis. This widespread presence in healthy animals may suggest that aureocin 
A70 is not directly involved in pathogenesis. It is interesting to note that the aurABCD 
operon of pRAM-28 is the most divergent yet differs by a single nucleotide mutation, 
leading to an L29F substitution in AurD. In fact, no single gene varies by more than a 
handful of substitutions. The remarkable conservation is evidence for dissemination via 
HGT, and the phylogeny of hosts suggests that the transfer is most likely mediated by 
conjugation between Staphylococcus. 
By focusing on the plasmidome, we were able to observe evidence of HGT in the 
dairy barn from which samples were collected. Two identical set of plasmids (pRAM-19-
1 and pRAM-19-2, as well as pRAM-30-1 and pRAM-30-2) were recovered from hosts 
from distinct bacterial phyla. In one case, a Gram-negative pathogen, K. pneumoniae, that 
was determined to be the causing agent of mastitis in the animal it was recovered from. 
It harbored two plasmids that were identical to plasmids found in B. licheniformis (a 
common Gram-positive member of the rumen microbiome224) isolated from a healthy 
host intramammary swab sample.  
Horizontal gene transfer has been reported in a myriad of environments, such as 
in the gut microbiome163,225,226, plant surface227, food waste composting228, cheese rind229, 
and hospital inhalable particulate matter230. However, this is the first time, to our 
knowledge, where evidence of plasmid transfer has been identified among two different 
cattle hosts sharing a barn. While gene exchange within phyla is widely reported231–235, 
HGT across phyla is reportedly more rare. It has, nonetheless, been reported between 
Spirochaetes and Firmicutes236, Proteobacteria and Firmicutes, and Proteobacteria and 
Actinobacteria237. Recently, it has been observed between Mycobacterium (Tenericutes) 
and Actinobacteria238, as well as between Mucispirillum schaedleri (Deferribacteres) and 
Proteobacteria239. 
A bioinformatic analysis done by Caro-Quintero & Konstantinidis (2014) 
evaluated quantitatively inter-phylum HGT, taking in consideration the environment and 
ecological conditions237. Their pipeline estimated the HGT across taxa while minimizing 
the effect of taxonomic representation. Not surprisingly, this study pointed out that shared 
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ecology, oxygen tolerance and other physiological parameters influence the frequency of 
gene exchange among bacteria. Interestingly, the removal of the phylum Firmicutes in a 
sample set reduced the horizontal gene transfer by 97%, indicating that this phylum is an 
important and promiscuous part in HGT. Furthermore, their results suggest that lateral 
transfer between distantly related organisms can be favored when both organisms have 
overlapping ecology. This study agrees with these findings, since Firmicutes were part of 
all the sets of identical plasmids detected and the bacterial hosts were isolated from 
similar ecological niches.  
Evans et al. (2020) suggest that highly identical plasmids are evidence of recent 
transfer, since the mutation rates of plasmids are similar to the chromosome and may not 
have the necessary time to diverge and adapt to its bacterial hosts231. The fact that the 
cloacin peptide encoded by pRAM-19-2, pRAM-12 and pRAM-30-2 was 100% identical 
to the peptide produced by diverse members of Enterobacteriaceae, while being only 93.4 
to 95.5% identical to the cloacin peptide previously detected in the Firmicutes phylum 
could suggest the direction of genetic exchange in this case. While we cannot determine 
with certainty the direction of the genetic exchange, this result highlights the fact that 
pathogens are interacting with the host’s natural flora: RAM-19 was identified as the 
causative agent of mastitis in the animal it was isolated from, while RAM-12 and RAM-




By focusing on a specific genetic context – plasmids – we were able to detect four 
different BGCs encoding small molecules, including the only known four-peptide 
leaderless bacteriocin. This approach also showed great potential for identifying genes 
responsible for antibiotic resistance and identifying uncharacterized genes for future 
study. More so, it allows the link between host and plasmid to be used in decision making 
after gene identification. Overall, this work suggests that the plasmidome is an important 
source of potential small molecules that are used by bacteria to compete with each other 
within and between microbiomes. By concentrating on plasmids purified from cultured 
host bacteria, we were also able to provide evidence for genetic exchange via plasmids, 
illustrating the intimacy of interactions within animal-associated microbial communities.  
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5 General Discussion 
 
5.1 Summary and limitations of this work 
 
This work aimed to shine a light on a frequently neglected genetic space: the 
plasmidome. Prioritization of the plasmidome can allow for the discovery of new 
biosynthetic gene clusters, as shown in this work. Using computational tools, we were 
able to show that plasmids have great potential as sources of secondary metabolites 
BGCs. In a practical approach, plasmids were isolated from animal microbiomes. 
Sequencing of the plasmids allowed the identification of four bioactive gene clusters in 
six plasmids. 
Chapter 3 intended to analyze publicly available plasmid sequences to determine 
the type of product, taxonomic distribution and prevalence of biosynthetic gene cluster. 
Using the software deepBGC and antiSMASH, we determined that the different classes 
of BGCs are present in most phyla. Since the two programs use distinct approaches for 
detection and identification, the number of BGCs as well as their product classes varied. 
Despite the discrepancy in the results, we were able to show that plasmids are a productive 
source for secondary metabolites with the potential to be used in medicine and veterinary 
sciences. However, the computational work done in Chapter 3 has its limitations, 
regardless of the individual restraints of each software. The biggest of which is the lack 
of a “control group”. Ideally, a manual investigation would allow us to infer which 
software was more accurate in the predictions. However, due to the sample size (n=101 
415), that was not practical. The sample size also restrained sequence dereplication.  
Chapter 4 aimed to use plasmid screening techniques to characterize plasmids 
present in animal-related microbiomes. Plasmids isolated from different sources were 
screened for different purposes. One of the limitations of the study of plasmid-mediated 
antibiotic resistance developed in this work is that the genes responsible remain unknown, 
since no sequencing or gene identification via PCR was done. As for the cat microbiota 
and bovid-related microbiome members, only bacteria that harbored plasmids were 
identified, which does not represent the whole bacteria community found in these spaces. 
Furthermore, only culturable bacteria were screened. This represents only a fraction of 
the microbial species present on Earth240. Plasmids were isolated from 38 bovid 
microbiome hosts. However, the method used to purify these plasmids is biased towards 
high molecular weight plasmids. Only a fraction of the plasmids was sequenced (12/38), 
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which is also a limitation of this study. Regarding plasmid annotation, manual 
intervention resulted in gene clusters that were not detected by either software used. This 
shows not only a constraint of this work, but also that, even thought we have consolidated 
bioinformatic tools available, there’s still room for development and growth of the 
computational tools accessible to researchers. 
The focus on plasmids permitted the detection of four BGCs encoding small 
molecules in six plasmids. The plasmidome approach also displayed potential in the 
identification of uncharacterized genes and gene clusters for future studies, as well as 
identifying plasmids connected to antibiotic resistance. Evidence of genetic exchange via 
plasmids, showing the close interactions of animal-associated microbiomes, was also 
provided. This work suggests the plasmidome as not only a source of small molecules, 
but as means for the deeper understanding of microbial interactions, antibiotic resistance 
and virulence mechanisms. 
 
5.2 Future prospects 
 
The need for new molecules is not new and is not going to go away anytime soon. 
As novel molecules get discovered, in vitro tests often quickly show that resistance is just 
around the corner. While that is not restricted to antibiotics, as this pattern has been seen 
in antiparasitic, antifungal and also in insecticide products, bacteria seem to be always a 
step ahead of us. Recent technological advances, such as NGS, and deeper understanding 
of microbial communities and the role played by their secondary metabolites, allowed the 
development of computational approaches to mine genomes for biosynthetic gene clusters 
with potential new bioactive products.  
As new bioinformatic tools and software are developed, more accurate BGCs 
predictions will be possible. However, the need to attempt to keep the bioinformatic 
approaches up-to-date with the recent literature and novel BGC classes discovered will 
always be a challenge. Said challenge is also extended to the ability of expression of 
cryptic and silent BGCs in vitro. As this work has shown the potential of plasmids for 
molecule discovery, it is expected that more research prioritizing this previously 
neglected space will surface. With that, the knowledge of how plasmids can mediate host 
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